Skip to content
Home/Companies/Pharma/Seqens
SE

Seqens

Pharma·France·Active·5yr hold

Seqens is a healthcare company, headquartered in France.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Seqens?

Seqens is currently owned by Eurazeo through Nov Sante Actions Non Cotees (2020 vintage), since 2021. Across its history, Seqens has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Eurazeo
Most recent investor
Eurazeo
Nov Sante Actions Non Cotees · 2020 · Healthcare
4 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

4 ownership periods · co-invest detected

Active
Co-held by Merieux Equity Partners, Ardian and Eurazeo since 2016.
Ardian
ArdianExited 2016
2011 · 2016 · Ardian Buyout Fund V · 2012 · Buyout
MOIC
–
Co-invest · 3 holders · 2016 · present
Merieux Equity Partners
Merieux Equity PartnersActive
2016 · present · Mérieux Participations 2 · 2014 · Buyout
MOIC
–
Ardian
ArdianActive
2016 · present · Ardian Co-Investment Fund IV · 2015 · Buyout
MOIC
–
Eurazeo
EurazeoActive
2021 · present · Nov Sante Actions Non Cotees · 2020 · Healthcare
MOIC
–

More from Nov Sante Actions Non Cotees

Other portfolio companies in the same fund.

Proteor
Active
MedTechFrance· 2025
Imapole
Active
MedTechFrance· 2023
Kinvent
Active
MedTechFrance· 2023
Horus Pharma
Active
HealthcareFrance· 2022
Oncodesign
Active
BiotechFrance· 2022
Groupe PSIH
Active
HealthTechFrance· 2021

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Delpharm
Active
SocadifFrance
Laboratoires Delbert
Active
SocadifFrance
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
Dec Group
Active
capitonSwitzerland· 2025
Essential Pharma
Active
Penta CapitalUK· 2025
Data refreshed weekly · Sourced from public filings